Reports

• Publish Date: Sep-2024
• Report Code: 3-8-1892
• Price: $ 4250/-

Global Oncolytic Virotherapy Market is valued at approximately USD 20.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 26.92% over the forecast period 2024-2032. Oncolytic virotherapy is a pioneering approach to cancer treatment that utilizes genetically engineered viruses to selectively infect and...

• Publish Date: Sep-2024
• Report Code: 3-8-1891
• Price: $ 4250/-

Global Insurance Brokerage Market is valued approximately at USD 283.85 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.3% over the forecast period 2024-2032. Insurance brokers act as essential intermediaries between policyholders and insurers, providing technical and professional advice about insurance products....

• Publish Date: Sep-2024
• Report Code: 3-8-1890
• Price: $ 4250/-

The Global Hydroprocessed Esters and Fatty Acids (HEFA) Market was valued at approximately USD 13.3 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.0% over the forecast period 2024-2032. The rise in air traffic is significantly driving the HEFA market value. HEFA...

• Publish Date: Sep-2024
• Report Code: 3-8-1889
• Price: $ 4250/-

Global Growth Hormone Deficiency Market is valued approximately at USD 4.38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.49% over the forecast period 2024-2032. Growth Hormone Deficiency (GHD) is a medical condition where the body does not produce enough growth hormone,...